Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: A meta-analysis

被引:64
|
作者
Yao, Yao [1 ,2 ]
Ma, Cai-hong [3 ]
Tang, Hui-lin [1 ]
Hu, Yong-fang [1 ]
机构
[1] Peking Univ, Hosp 3, Therapeut Drug Monitoring & Clin Toxicol Ctr, Beijing 100191, Peoples R China
[2] Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100191, Peoples R China
[3] Peking Univ, Hosp 3, Ctr Reprod Med, Beijing 100191, Peoples R China
关键词
IVF; FSHR; Single nucleotide polymorphism; Meta-analysis; GENE POLYMORPHISMS; HYPERSTIMULATION; IVF; PHARMACOGENETICS; INFERTILITY; GENOTYPE;
D O I
10.1016/j.ymgme.2011.04.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A common follicle-stimulating hormone (FSH) receptor (or FSHR) polymorphism Ser680Asn (rs6166) was found to be associated with altered ovarian response in women undergoing in-vitro fertilization. To further investigate such an association, a meta-analysis was conducted. Methods: A PubMed literature search was conducted to identify all cohort studies investigating such a relationship. The following parameters-basal FSH levels, total FSH doses, oocytes retrieved, and pregnancy rates-were used to evaluate the ovarian function, its response to exogenous FSH and in-vitro fertilization and intracytoplasmic sperm injection outcome. Results: A total of 1421 cases were collected from eight studies. Of them, a significantly lower basal FSH level was observed in patients harboring Asn/Asn (NN) genotype than those carrying the Ser/Ser (SS) genotype both in Asian (WMD: -2.57 mIU/ml, 95% CI: -2.96 to -2.19, P<0.0001) and Caucasian retrospective groups (WMD: -1.86 mIU/ml, 95%CI: -2.07 to -1.66, P<0.0001) with no heterogeneity. Moreover, carriers of the SS tended to require greater FSH doses than NN (WMD: -268.82 IU, 95% CI: -561.28 to 23.63, P = 0.07). Other parameters, such as oocytes retrieved and pregnancy rate, were not significantly different between the groups. Conclusion: Carriers of the SS variant have slightly higher basal FSH levels, tending to require higher doses of exogenous FSH for stimulation. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:388 / 393
页数:6
相关论文
共 50 条
  • [41] Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis
    Bechtejew, T. N.
    Nadai, M. N.
    Nastri, C. O.
    Martins, W. P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2017, 50 (03) : 315 - 323
  • [42] Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction
    Daya, S
    FERTILITY AND STERILITY, 2002, 77 (04) : 711 - 714
  • [43] The effects of pure follicle-stimulating hormone versus human menopausal gonadotrophins on steroidogenesis and folliculogenesis during controlled ovarian hyperstimulation for in-vitro fertilization and embryo transfer
    Awwad, JT
    Sawaya, JT
    Leykin, L
    Isaacson, KB
    Sayegh, R
    Chen, Z
    Toth, TL
    HUMAN REPRODUCTION, 1998, 13 : 197 - 197
  • [44] Relative predictive value of patient age, follicle-stimulating hormone (FSH) and antral follicle count (AFC) for response to ovarian stimulation and outcome of in vitro fertilization (IVF) treatment.
    Chang, F. E.
    Mottla, G. L.
    Richter, K. S.
    Drake, M.
    FERTILITY AND STERILITY, 2007, 88 : S96 - S96
  • [45] Prediction of ovarian response and in-vitro fertilization outcome using age, follicle stimulating hormone (FSH), luteinizing hormone (LH), and FSH/LH ratio: a second look
    Lashen, H
    Ledger, W
    Lopez-Bernal, A
    Barlow, D
    HUMAN REPRODUCTION, 1999, 14 : 104 - 104
  • [46] COST SUBSTITUTION IMPACT ANALYSIS OF HIGH PURITY HUMAN URINARY FOLLICLE STIMULATING HORMONE FOR THE CONTROLLED OVARIAN STIMULATION IN IN-VITRO FERTILIZATION IN CHINA
    Xu, Y.
    Zhu, S.
    Zhang, Y.
    Wang, Z.
    Chen, T.
    Lin, Y.
    Xuan, J.
    VALUE IN HEALTH, 2019, 22 : S186 - S186
  • [47] Does Follicle-Stimulating hormone receptor polymorphism status affect In vitro fertilization-intracytoplasmic sperm injection results and live birth rate? A retrospective study
    Bayraktar, Burak
    Gulec, Ebru Sahin
    Kutbay, Yasar Bekir
    Kose, Can
    Gur, Esra Bahar
    Demir, Ahmet
    JOURNAL OF HUMAN REPRODUCTIVE SCIENCES, 2022, 15 (01) : 58 - 63
  • [48] Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis
    van Wely, M
    Westergaard, LG
    Bossuyt, PMM
    van der Veen, F
    FERTILITY AND STERILITY, 2003, 80 (05) : 1086 - 1093
  • [49] Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis
    Kolibianakis, E. M.
    Venetis, C. A.
    Diedrich, K.
    Tarlatzis, B. C.
    Griesinger, G.
    HUMAN REPRODUCTION UPDATE, 2009, 15 (06) : 613 - 622
  • [50] Comparison of the combination of recombinant follicle-stimulating hormone and recombinant luteinizing hormone protocol versus human menopausal gonadotropin protocol in controlled ovarian stimulation: A systematic review and meta-analysis
    Wang, Yuning
    Li, Ling
    Deng, Ke
    Liu, Jiali
    Liu, Yanmei
    Zou, Kang
    Hao, Guimin
    Sun, Xin
    JOURNAL OF EVIDENCE BASED MEDICINE, 2020, 13 (03) : 215 - 226